Organon on Pace for Highest Close Since October 2025 -- Data Talk

Dow Jones01-24

Organon & Co. ( OGN ) is currently at $9.81, up $0.07 or 0.72%

 

--Would be highest close since Oct. 9, 2025, when it closed at $9.92

--On pace for largest percent increase since Jan. 22, 2026, when it rose 1.56%

--Currently up nine consecutive days; up 21.86% over this period

--Longest winning streak on record (Based on available data back to May 14, 2021)

--Best nine day stretch since the nine days ending Dec. 26, 2023, when it rose 22.44%

--Up 11.99% this week; best weekly performance since the week ending Feb. 16, 2024, when it rose 14.22%

--Up 36.82% month-to-date; on pace for best month on record (Based on available data back to May 14, 2021)

--Up 36.82% year-to-date

--Down 75.08% from its all-time closing high of $39.36 on March 2, 2022

--Down 38.57% from 52 weeks ago (Jan. 24, 2025), when it closed at $15.97

--Down 39.89% from its 52-week closing high of $16.32 on Feb. 13, 2025

--Up 54.73% from its 52-week closing low of $6.34 on Oct. 29, 2025

--Traded as high as $9.94; highest intraday level since Oct. 9, 2025, when it hit $10.34

--Up 2.05% at today's intraday high

 

All data as of 3:10:56 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

January 23, 2026 15:15 ET (20:15 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment